Communiqués Xenetic Biosciences, Inc.

Actions

XBIO

US9840156023

Temps Différé Nasdaq Autres places de cotation 16:53:50 06/06/2024			Varia. 5j.	Varia. 1 janv.
3,98 ^USD	-1,08 %		+6,42 %	+15,36 %

22/05	Xenetic Biosciences, Inc. annonce la démission de ses dirigeants	CI
22/05	Xenetic Biosciences, Inc. annonce des changements au niveau de la direction générale	CI

Communiqués

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Xenetic Biosciences : Announces Executive Leadership Transition - Form 8-K	22/05	PU
Xenetic Biosciences, Inc. Reports First Quarter 2024 Financial Results and Provides Business Update	13/05	AQ
Xenetic Biosciences : Reports First Quarter 2024 Financial Results and Provides Business Update - Form 8-K	10/05	PU
Xenetic Biosciences: Q1 Earnings Snapshot	10/05	AQ
Xenetic Biosciences, Inc. Reports Full Year 2023 Financial Results	25/03	AQ
Xenetic Biosciences : Reports Full Year 2023 Financial Results - Form 8-K	22/03	PU
Xenetic Biosciences: Q3 Earnings Snapshot	10/11	AQ
Xenetic Biosciences, Inc. to Participate at the Virtual Investor Ask the CEO Conference	12/10/23	AQ
Xenetic Biosciences: Q2 Earnings Snapshot	11/08/23	AQ
Xenetic Biosciences: Q1 Earnings Snapshot	11/05/23	AQ
XENETIC BIOSCIENCES, INC. : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K)	11/05/23	AQ
Xenetic Biosciences : Reports Full Year 2022 Financial Results and Provides Business Update - Form 8-K	23/03/23	PU
XENETIC BIOSCIENCES, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)	22/03/23	AQ
XENETIC BIOSCIENCES, INC. : Submission of Matters to a Vote of Security Holders (form 8-K)	22/12/22	AQ
XENETIC BIOSCIENCES, INC. : Submission of Matters to a Vote of Security Holders (form 8-K)	09/12/22	AQ
XENETIC BIOSCIENCES, INC. : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (form 8-K)	02/12/22	AQ
Xenetic Biosciences: Q3 Earnings Snapshot	10/11/22	AQ
Xenetic Biosciences : Reports Third Quarter 2022 Financial Results and Provides Business Update - Form 8-K	10/11/22	PU
XENETIC BIOSCIENCES, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	09/11/22	AQ
Xenetic Biosciences : Private Placement - Form 8-K	12/10/22	PU

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués Xenetic Biosciences, Inc.

Actions

XBIO

US9840156023

Communiqués

Filtres